A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer

European Journal of Surgical Oncology

Volumn 40, Issue 3, 2014, Pages 311-317

  Xu, Y H ^a   Lu, S ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Meta analysis; Non small cell lung cancer; Phosphorylated STAT3; Prognosis; Signal transducer and activator of transcription 3 (STAT3); Survival

Indexed keywords

META-ANALYSIS; NON-SMALL-CELL LUNG CANCER; PHOSPHORYLATED STAT3; PROGNOSIS; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (STAT3); SURVIVAL;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; GENETIC MARKERS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PROGNOSIS; RETROSPECTIVE STUDIES; STAT3 TRANSCRIPTION FACTOR; SURVIVAL ANALYSIS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84893957093     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.11.012     Document Type: Article

References (26)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics CA Cancer J Clin 55 2005 74 108
2. W. Sun, L. Song, and T. Ai et al. Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer J Biomed Res 27 2013 220 230
3. J.R. Molina, P. Yang, S.D. Cassivi, S.E. Schild, and A.A. Adjei Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship Mayo Clin Proc 83 2008 584 594
4. J.E. Darnell Jr. STATs and gene regulation Science 277 1997 1630 1635
5. E.B. Haura, Z. Zheng, L. Song, A. Cantor, and G. Bepler Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer Clin Cancer Res 11 2005 8288 8294
6. H. Yu, and R. Jove The STATs of cancer-new molecular targets come of age Nat Rev Cancer 4 2004 97 105
7. M.K. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 1998 2815 2834
8. J. Lau, J.P. Ioannidis, and C.H. Schmid Quantitative synthesis in systematic reviews Ann Intern Med 127 1997 820 826
9. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta analysis detected by a simple, graphical test BMJ 315 1977 629 634
10. Zhenfa Zhang, Jianqun Ma, and Nan Sun Expression of STAT3 and M APK in non-small cell lung cancer and their clinical significance Chin J Clin Oncol 31 2004 349 355
11. Nan Sun, Dali Tian, Xiang Zhao, Zhen-fa Zhang, Lin Zhang, and Shun-shou Liu Expression of STAT3 in non-small cell lung cancer and its relationship with prognosis China J Mod Med 16 2006 2906 2916
12. T. Cortas, R. Eisenberg, P. Fu, J. Kern, L. Patrick, and A. Dowlati Activation state EGFR and STAT-3 as prognostic markers in resected non-small cell lung cancer Lung Cancer 55 2007 349 355
13. Galleges-Ruiz MI (Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.) K. Floor, S.M. Steinberg, and K. Grunberg et al. Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients Br J Cancer 100 2009 145 152
14. Hyeong Su Kim, Yeon Hee Park, and Jeeyun Lee et al. Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray Cancer 10 2010 676 685
15. Meng Wang, Gongyan Chen, and Hongtao Song et al. Significance of CXCR4, phosphorylated STAT3 and VEGF-A expression in resected non-small cell lung cancer Exp Therap Med 235 2011 517 522
16. Z. Yin, Y. Zhang, Y. Li, T. Lv, J. Liu, and X. Wang Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells Acta Histochem 114 2012 151 158
17. R.M. Bremnes, R. Veve, and E. Gabrielson et al. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer J Clin Oncol 20 2002 2417 2428
18. G. Deeb, J. Wang, and N. Ramnath et al. Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry Mod Pathol 17 2004 430 439
19. O. David, J. Jett, and H. LeBeau et al. Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage Clin Cancer Res 10 2004 6865 6871
20. N. Kanda, H. Seno, and Y. Konda et al. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells Oncogene 23 2004 4921 4929
21. X. Zhang, P. Liu, B. Zhang, A. Wang, and M. Yang Role of STAT3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells Cancer Genet Cytogenet 197 2010 46 53
22. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas Blood 111 2008 1515 1523
23. G. Yang, C. Huang, J. Cao, K.J. Huang, T. Jiang, and Z.J. Qiu Lenti-virus mediated shRNA interference targeting STAT3 inhibits human pancreatic cancer cell invasion World J Gastroenterol 15 2009 3757 3766
24. H. Min, and Z. Wei-Hong Constitutive activation of signal transducer and activator of transcription 3 in epithelial ovarian carcinoma J Obstet Gynaecol Res 35 2009 918 925
25. E. Pectasides, A.M. Egloff, and C. Sasaki et al. Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis Clin Cancer Res 16 2010 2427 2434
26. K. Ryu, E. Choy, and C. Yang et al. Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis J Orthop Res 28 2010 971 978